GL1X · GenesisL1 explorer

MolNFT v1 · #116539 · protein

Crystal structure of HIV-1 protease inhibitor grl-105-11A containing substituted fused-tetrahydropyranyl tetrahydrofuran as P2-ligand

5DGW · Pol protein: “Crystal structure of HIV-1 protease inhibitor grl-105-11A containing substituted fused-tetrahydropyranyl…”. X-ray diffraction, 3 ligands (5B5, NA, CL), 1 pocket (best druggability 0.73). MolNFT v1 #116539 on GenesisL1…

PDB
5DGW
Type
protein
Length
198 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Pol protein
UniProt
Q8Q3H0
Ligands
5B5, NA, CL
Pockets
1 · best druggability 0.73

Structure

x-ray diffraction · 1 distinct chain · 7% helix, 54% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, BPol proteinprotein997% helix, 54% strandQ8Q3H0

Ligands and binding sites

  • 5B5 · (3R,3aS,4S,7aS)-3-(ethylamino)hexahydro-4H-furo[2,3-b]pyran-4-yl [(2S,3R)-3-hydroxy-4-{[(4-methoxyphenyl)sulfonyl](2-methylpropyl)amino}-1-phenylbutan-2-yl]carbamate · ligand · chains A, B
  • NA · Sodium ion · metal · chains A
  • CL · Chloride ion · ion · 3 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
14270.730.83355B5

Interfaces

1 interface between chains.

  • A–B · 1871 Ų buried · 37 hydrogen bonds · protein-protein

Compared structures

  • 5DGW · Crystal Structure of HIV-1 Protease Inhibitor GRL-105-11A Containing Substituted… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.